Sinovac Biotech Ltd (NASDAQ:SVA)
| -- Delayed Data As of -- | -- -- / -- Today’s Change | -- |||52-Week Range -- | -- Year-to-Date |
Latest SVA News | Press Releases
No recent news for Sinovac Biotech Ltd.
Today’s Trading
| Previous close | 6.47 |
| Today’s open | -- |
| Day’s range | -- - -- |
| Volume | 0 |
| Average volume (3 months) | -- |
| Market cap | $644.8M |
Data as of --
Growth & Valuation
| Earnings growth (last year) | +7,974.45% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | +3,694.36% |
| P/E ratio | 19.0 |
| Price/Sales | -- |
| Price/Book | 0.07 |
Competitors
| ---- | ||
| ARCTArcturus Therapeutic... | +3.30 | +15.99% |
| HROWHarrow Health Inc | -0.11 | -0.52% |
| IDYAIDEAYA Biosciences I... | +0.23 | +1.70% |
Data as of 4:00pm ET, 03/31/2023
Financials
| Last reporting date | April 11, 2017 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $19.4B |
| Annual profit (last year) | $8.5B |
| Net profit margin | 43.70% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Beijing, Beijing |
Forecasts
Chart unavailable
